HOME >> BIOLOGY >> NEWS
New Faculty of 1000 service offers a unique evaluation system for research papers in the life sciences

Faculty of 1000 is a unique service, provided by BioMed Central, for research scientists that systematically highlights and evaluates the most interesting papers published in the biological sciences, based on the recommendations of over 1000 leading researchers.

Faculty of 1000 is divided into 16 subject areas (Faculties), which are subdivided, in turn, into Sections. Each Section is assigned Faculty members representing the leading researchers in those areas. Faculty members evaluate 2-4 of the most interesting papers that they read each month.

Each evaluation consists of a brief comment on why the paper is important accompanied by any of four classifications: novel finding, technical advance, interesting hypothesis or important confirmation. The papers are also given a rating depending on whether they are of specialist interest, of general interest, or a landmark paper representing the top 1% of publications. The consensus rating for each paper (F1000 Factor) is represented by a number calculated on the basis of the ratings awarded and the number of faculty members choosing that paper. This offers an immediate rating of individual papers by the authors peers, and a first real alternative to the indirect assessment provided by the journal impact factor

Faculty of 1000 has been created to provide a rapidly updated consensus map of the most important papers and trends across biology and so addresses a real need felt by the biological community.

Stan Falkow, Faculty head for Microbiology, said:

The mass of literature is overwhelming, and a systematic tool that organizes and evaluates it authoritatively like this is just what we need.

Similarly, Tony Pawson, Faculty head for Cell Biology is equally enthusiastic about Faculty of 1000:

I visited the web site, and got immediately excited. This is just what we need.

Faculty of 1000 will help all biologists in their work
'"/>

Contact: Gordon Fletcher
gordon@biomedcentral.com
44-20-7323-0323
BioMed Central
21-Nov-2001


Page: 1 2

Related biology news :

1. Faculty of 1000 - Highlighting quality scientific research
2. NSFs Highest Honor For New Faculty Fosters Integration Of Research And Education
3. Early Career Development Grants Foster Faculty Research And Education
4. UK small firms pay lip service to green issues
5. DCI donor services begins distribution of tissue implants
6. Nerac rebuilds TOC Journal Watch service with new search engine
7. Children with HIV more likely to utilize health services than infected adults
8. Certified professionals to serve as technical service providers under Farm Bill 2002
9. Clinical services must catch up
10. Applying ecosystem services
11. URI researcher receives park service grant to identify environmental threats to wetlands in the northeast park system

Post Your Comments:
(Date:2/5/2015)... , Jan. 26, 2015   Epic Sciences , a ... today announced that Murali Prahalad , Ph.D., president and ... World Conference (PMWC) 2015: Silicon Valley, which is taking ... View, Calif. on January 26-28, 2015. ... of Age as Biomarkers." Last year, Epic Sciences was a ...
(Date:2/5/2015)... 2015 New Market Research Reports ... Forecasts To 2020 has Been Added to GrandViewReseach.com Report ... expected to reach USD 5.10 billion by 2020, according ... IR cameras help identify the site of tissue damage ... surging demand in medical imaging applications. They have been ...
(Date:2/5/2015)... 30, 2015  It is gratifying to see that ... for genomic science as a means to better understand ... treatment.  I was honored to participate in today,s White ... program. Since the 1980s my teams ... the first sequenced genome of a free living organism, ...
Breaking Biology News(10 mins):Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2
(Date:2/27/2015)... CA (PRWEB) February 27, 2015 Cytokinetics, ... forces on February 28 with patients and health care ... awareness for Rare Disease Day®. Rare Disease Day ... and calling attention to the special challenges faced by ... them. , “Cytokinetics is proud to stand alongside patients ...
(Date:2/26/2015)... , Feb. 26, 2015 S&P Capital ... Factual Stock Report coverage on MabVax Therapeutics Holdings Inc ... is a clinical stage biotechnology company focused on the ... medical needs in the treatment of cancer. MabVax has ... on the protective immune responses generated by patients who ...
(Date:2/26/2015)... SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; ... commercializes proprietary technologies and products for advanced microarray diagnostics, ... fiscal first quarter ended December  31, 2014. All figures ... unless otherwise stated. "During the quarter ... existing customers and add to our sales pipeline," said ...
(Date:2/26/2015)... Feb. 26, 2015 Protiviti ( www.protiviti.com ), ... of the Governance Portal , designed to increase ... compliance (GRC) tasks across multiple business units and projects. ... help customers better align their controls with the COSO ... ) requirements. In response to client feedback, Protiviti has ...
Breaking Biology Technology:Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 6S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5SQI Diagnostics Reports First Quarter Financial Results 2SQI Diagnostics Reports First Quarter Financial Results 3SQI Diagnostics Reports First Quarter Financial Results 4SQI Diagnostics Reports First Quarter Financial Results 5SQI Diagnostics Reports First Quarter Financial Results 6Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 2Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 3
Cached News: